Mozifor 20mg Injection contains Plerixafor, which is used to mobilize hematopoietic stem cells (HSCs) in the bloodstream for collection and transplantation. For patients receiving autologous stem cell transplantation, this specialty medication is frequently used in conjunction with granulocyte colony-stimulating factor (G-CSF), usually to treat certain diseases such as multiple myeloma or non-Hodgkin's lymphoma.
Mozifor 20mg Injection contains Plerixafor, which is used to mobilize hematopoietic stem cells (HSCs) in the bloodstream for collection and transplantation.
Brand Name: Mozifor
Composition: Plerixafor
Mechanism of Action:
Plerixafor is a CXCR4 antagonist that functions by preventing stromal cell-derived factor-1α (SDF-1α) from attaching to the hematopoietic stem cells' CXCR4 receptor. This promotes the release of HSCs into the bloodstream by interfering with their ability to remain in the bone marrow. Following mobilization, the stem cells can be harvested for transplantation.
Uses:
Stem Cell Transplantation
Dosage and Administration:
The recommended dose is 0.24 mg/kg body weight, administered subcutaneously.
Side Effects:
Safety Advise:
Liver 
Information regarding the use of Mojifor 20mg Injection in liver disease patients is minimal. Kindly speak with your healthcare provider.
Kidney
Information regarding the use of Mojifor 20mg Injection in kidney disease patients is minimal. Kindly speak with your healthcare provider.
Pregnancy
Rituximab should only be used during pregnancy if clearly needed, as it can harm the fetus. Kindly speak with your healthcare provider.
Breastfeeding
Nursing mothers should not get a 20mg injection of Mojifor unless truly necessary. Kindly speak with your healthcare provider.
Alcohol
When using Mojifor 20mg Injection with alcohol, caution is suggested. Kindly speak with your healthcare provider.
Storage:
Store in a refrigerator between 2°C to 8°C. Do not freeze or shake the vial.
How to use this medication?
Plerixafor injection is a liquid that a physician or nurse administers subcutaneously, or beneath the skin, in a medical facility. For up to four consecutive days, it is typically administered once daily, eleven hours before to the blood cell extraction. You will start receiving a G-CSF medicine once daily for four days before to starting plerixafor injection treatment, and you will continue to get the G-CSF medication during your plerixafor injection treatment.
Disclaimer:
The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.
Marketer details
Name: Hetero Drugs Ltd
Address: 7-2-A2, Hetero Corporate, Industrial Estates, Sanath Nagar, Hyderabad – 500 018. Telangana, INDIA
Country of origin: India
We deliver within Bangalore city limits in 24 hours for orders above ₹10,000, with exceptions based on location, while other deliveries rely on trusted courier partners and their timelines.
We provide only authentic, verified medicines sourced from manufacturers or authorized distributors, ensuring proper cold chain storage throughout delivery.
We are available around the clock to assist you.
Shop with confidence, knowing your data is safe with us.
